Skip to content

Ropivacaine as an Intrathecal Agent Part 3: The Addition of Fentanyl

Ropivacaine as an Intrathecal Agent Part 3: The Addition of Fentanyl

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002932
Enrollment
Unknown
Registered
2012-12-29
Start date
2000-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Pregnant patients presenting for Elective Caesarean Delivery

Interventions

Sponsors

Internally Funded by The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy ASA 1 & 2 patients presenting for elective Caesarean Delivery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patients who do not conform to the inclusion criteria, including those with neurological disease, coagulopathy, heart disease

Design outcomes

Primary

MeasureTime frame
Successful Anaesthesia;

Countries

China

Contacts

Public ContactKhaw Kim Sun
kimkhaw@cuhk.edu.hk+852 26322735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026